- Stock: In Stock
- Brand: Beximco Pharmaceutical
- Product ID: Acetylcysteine
Available Options
100% Secure Payment
bKash | Nagad | Cards via SSLCommerz | COD
Monthly Medicines Available | Free Delivery on Eligible Orders
Mucomist DT 600mg Tablet — Acetylcysteine 600mg Dispersible Tablet | Beximco Pharmaceuticals
| Generic Name | Acetylcysteine (N-Acetylcysteine / NAC) 600 mg |
| Dosage Form | Dispersible Tablet (DT) — dissolves in water to form effervescent solution |
| Manufacturer | Beximco Pharmaceuticals Ltd. |
| Therapeutic Class | Mucolytic Agent (Oral) |
| Route of Administration | Oral (dissolve in water and drink) |
| Availability | In Stock — Available Online |
Overview
Mucomist DT 600mg is an oral dispersible tablet containing Acetylcysteine (NAC) 600 mg. The DT (dispersible tablet) formulation dissolves in a glass of water to produce a drinkable solution — making it easy to swallow, particularly for elderly patients or those who have difficulty with conventional tablets. When taken orally, NAC is absorbed into the bloodstream and reaches the respiratory tract systemically, where it reduces mucus viscosity and supports airway clearance. Mucomist DT is an effective, well-tolerated mucolytic for chronic and acute respiratory conditions accompanied by productive cough and thick secretions.
Mechanism of Action
Acetylcysteine is a precursor to glutathione, the primary intracellular antioxidant. When absorbed, it:
- Mucolytic effect: Breaks disulfide bonds in mucus glycoproteins, reducing mucus viscosity and making secretions easier to cough up
- Antioxidant effect: Replenishes glutathione, scavenges ROS from activated neutrophils and macrophages in the inflamed airway — reduces oxidative damage in COPD and chronic bronchitis
- Anti-inflammatory: Reduces NF-κB activation and production of pro-inflammatory cytokines (IL-8, TNF-α) that perpetuate airway inflammation
Indications
- COPD with Chronic Mucus Hypersecretion — reduces exacerbation frequency (evidence base: BRONCUS trial); improves exercise tolerance
- Chronic Bronchitis — daily maintenance mucolytic therapy
- Acute Bronchitis with Productive Cough — shortens duration of thick mucus phase
- Bronchiectasis — systemic mucolytic to facilitate daily mucus clearance
- Post-Respiratory Infection Mucus Clearance — following pneumonia or influenza
Dosage & Administration
| Patient Group | Dose | Frequency |
|---|---|---|
| Adults (≥18 yr) — Maintenance | 1 tablet (600 mg) | Once daily |
| Adults — Acute Use | 1 tablet (600 mg) | Once to twice daily (as directed) |
| Children (under 18) | Under physician guidance only | — |
How to take: Drop one tablet into a glass of water (at least 100–150 mL). Allow to fully dissolve (approximately 1–2 minutes). Drink immediately after dissolving. Take after meals to reduce stomach irritation. Drink plenty of additional fluids throughout the day — adequate hydration enhances the mucolytic effect.
Mucomist DT vs Mucomist Respirator Solution
| Feature | Mucomist DT 600mg (Oral) | Mucomist 600mg Respirator Solution |
|---|---|---|
| Route | Oral — systemic absorption | Inhalation — direct airway action |
| Onset | Slower (30–90 min systemic absorption) | Faster (direct airway contact) |
| Nebulizer needed? | No | Yes |
| Convenience | High — dissolve in water and drink | Requires nebulizer, time, and technique |
| Best for | Outpatient maintenance, home use | Severe acute episodes, hospital/clinic setting |
Special Note for Diabetic Patients
NAC has no direct hypoglycaemic or hyperglycaemic effect. Mucomist DT 600mg is safe for patients with diabetes who have concurrent respiratory conditions requiring mucolytic therapy. Some research suggests NAC may have mild insulin-sensitising antioxidant effects, but this is not a primary indication and should not be relied upon for glycaemic management.
Drug Interactions
| Drug | Interaction |
|---|---|
| Antitussives (cough suppressants) | Avoid combining — suppressing cough negates mucolytic benefit |
| Nitroglycerin | May potentiate vasodilation — monitor blood pressure |
| Activated charcoal | Reduces NAC absorption if taken simultaneously |
| Antibiotics | No interaction when taken orally at different times; do not mix in liquid |
Side Effects
- Common: Mild nausea, vomiting, stomach discomfort (take after meals to reduce)
- Uncommon: Headache, tinnitus, fever
- Rare: Hypersensitivity reactions — rash, urticaria, bronchospasm
Storage
- Store below 25°C, protected from moisture. Keep in original packaging. Keep out of reach of children.
FAQ
Q1: How long does it take Mucomist DT to work?
After oral intake, acetylcysteine is absorbed and reaches systemic circulation within 30–90 minutes. Mucolytic effects on airway secretions typically begin within a few hours. Patients usually notice easier expectoration after 1–3 days of regular use. For chronic conditions (COPD, chronic bronchitis), continued daily use provides sustained benefit.
Q2: Can I take Mucomist DT with my diabetes medications?
Yes. Acetylcysteine does not interfere with commonly prescribed diabetes medications including metformin, sulfonylureas, insulin, DPP-4 inhibitors, or SGLT-2 inhibitors. However, always inform your physician of all medications you take.
Q3: Should I take Mucomist DT with food?
Taking it after a meal can reduce nausea. There is no significant effect of food on absorption. Drink plenty of water throughout the day — good hydration enhances the mucolytic effect and helps loosen mucus further.
Q4: Can I take cough syrup alongside Mucomist DT?
Avoid combining with cough suppressants (e.g., dextromethorphan, codeine). If NAC loosens mucus but cough is suppressed, the secretions cannot be cleared — potentially worsening the condition. Expectorant cough syrups (guaifenesin) may be combined. Ask your physician.
Medical Disclaimer: Educational information only. Always use under the guidance of a licensed physician.
